These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
863 related articles for article (PubMed ID: 20689242)
1. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice. Hedberg MM; Clos MV; Ratia M; Gonzalez D; Lithner CU; Camps P; Muñoz-Torrero D; Badia A; Giménez-Llort L; Nordberg A Neurodegener Dis; 2010; 7(6):379-88. PubMed ID: 20689242 [TBL] [Abstract][Full Text] [Related]
2. Transgenic mice overexpressing human acetylcholinesterase and the Swedish amyloid precursor protein mutation: effect of nicotine treatment. Hedberg MM; Svedberg MM; Mustafiz T; Yu WF; Mousavi M; Guan ZZ; Unger C; Nordberg A Neuroscience; 2008 Mar; 152(1):223-33. PubMed ID: 18164554 [TBL] [Abstract][Full Text] [Related]
3. Huprine X and huperzine A improve cognition and regulate some neurochemical processes related with Alzheimer's disease in triple transgenic mice (3xTg-AD). Ratia M; Giménez-Llort L; Camps P; Muñoz-Torrero D; Pérez B; Clos MV; Badia A Neurodegener Dis; 2013; 11(3):129-40. PubMed ID: 22626981 [TBL] [Abstract][Full Text] [Related]
4. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline. Clausen A; Xu X; Bi X; Baudry M J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441 [TBL] [Abstract][Full Text] [Related]
5. Effect of subchronic treatment of memantine, galantamine, and nicotine in the brain of Tg2576 (APPswe) transgenic mice. Unger C; Svedberg MM; Yu WF; Hedberg MM; Nordberg A J Pharmacol Exp Ther; 2006 Apr; 317(1):30-6. PubMed ID: 16354790 [TBL] [Abstract][Full Text] [Related]
6. Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease. Hernandez CM; Kayed R; Zheng H; Sweatt JD; Dineley KT J Neurosci; 2010 Feb; 30(7):2442-53. PubMed ID: 20164328 [TBL] [Abstract][Full Text] [Related]
7. Huprine X Attenuates The Neurotoxicity Induced by Kainic Acid, Especially Brain Inflammation. Relat J; Pérez B; Camps P; Muñoz-Torrero D; Badia A; Victòria Clos M Basic Clin Pharmacol Toxicol; 2018 Jan; 122(1):94-103. PubMed ID: 28724203 [TBL] [Abstract][Full Text] [Related]
8. Temporal changes of CD68 and α7 nicotinic acetylcholine receptor expression in microglia in Alzheimer's disease-like mouse models. Matsumura A; Suzuki S; Iwahara N; Hisahara S; Kawamata J; Suzuki H; Yamauchi A; Takata K; Kitamura Y; Shimohama S J Alzheimers Dis; 2015; 44(2):409-23. PubMed ID: 25352454 [TBL] [Abstract][Full Text] [Related]
9. Elevated levels of Abeta1-40 and Abeta1-42 do not alter the binding sites of nicotinic receptor subtypes in the brain of APPswe and PS1 double transgenic mice. Marutle A; Unger C; Hellström-Lindahl E; Wang J; Puoliväli J; Tanila H; Nordberg A; Zhang X Neurosci Lett; 2002 Aug; 328(3):269-72. PubMed ID: 12147323 [TBL] [Abstract][Full Text] [Related]
10. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease. Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994 [TBL] [Abstract][Full Text] [Related]
11. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease. Wu X; Kosaraju J; Zhou W; Tam KY ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988 [TBL] [Abstract][Full Text] [Related]
12. Intraneuronal beta-amyloid accumulation in the amygdala enhances fear and anxiety in Alzheimer's disease transgenic mice. España J; Giménez-Llort L; Valero J; Miñano A; Rábano A; Rodriguez-Alvarez J; LaFerla FM; Saura CA Biol Psychiatry; 2010 Mar; 67(6):513-21. PubMed ID: 19664757 [TBL] [Abstract][Full Text] [Related]
14. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease. Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747 [TBL] [Abstract][Full Text] [Related]
15. Fibrillar Amyloid-β Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3×Tg-AD Transgenic Mouse. Ontiveros-Torres MÁ; Labra-Barrios ML; Díaz-Cintra S; Aguilar-Vázquez AR; Moreno-Campuzano S; Flores-Rodríguez P; Luna-Herrera C; Mena R; Perry G; Florán-Garduño B; Luna-Muñoz J; Luna-Arias JP J Alzheimers Dis; 2016 Mar; 52(1):243-69. PubMed ID: 27031470 [TBL] [Abstract][Full Text] [Related]
16. Decreased accumulation of subcellular amyloid-β with improved mitochondrial function mediates the neuroprotective effect of huperzine A. Yang L; Ye CY; Huang XT; Tang XC; Zhang HY J Alzheimers Dis; 2012; 31(1):131-42. PubMed ID: 22531425 [TBL] [Abstract][Full Text] [Related]
17. Huprine X is a novel high-affinity inhibitor of acetylcholinesterase that is of interest for treatment of Alzheimer's disease. Camps P; Cusack B; Mallender WD; El Achab RE; Morral J; Muñoz-Torrero D; Rosenberry TL Mol Pharmacol; 2000 Feb; 57(2):409-17. PubMed ID: 10648652 [TBL] [Abstract][Full Text] [Related]